The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
Journal for ImmunoTherapy of Cancer.
Times cited: 26
Scientific advances in lung cancer 2015.
Journal of Thoracic Oncology.
Times cited: 107
Pilot randomized phase II study of celecoxib in oral premalignant lesions.
Clinical Cancer Research.
Times cited: 73
An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.
Journal of Clinical Oncology.
Times cited: 118